21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using tebentafusp in the NHS in England.

Tebentafusp is not recommended for the treatment of adults with HLA-A*02:01-positive unresectable or metastatic uveal melanoma.

Read NICE appraisal consultation document